SenzaGen AB (SENZA.ST)

SEK 5.26

(-0.38%)

Total Liabilities Summary of SenzaGen AB

SenzaGen AB's latest annual total liabilities in 2023 was 29.56 Million SEK , down -2.26% from previous year.
SenzaGen AB's latest quarterly total liabilities in 2024 Q2 was 26.67 Million SEK , up 1.37% from previous quarter.
SenzaGen AB reported annual total liabilities of 30.25 Million SEK in 2022, up 28.4% from previous year.
SenzaGen AB reported annual total liabilities of 23.56 Million SEK in 2021, up 527.32% from previous year.
SenzaGen AB reported quarterly total liabilities of 26.31 Million SEK for 2024 Q1, down -10.99% from previous quarter.
SenzaGen AB reported quarterly total liabilities of 29.56 Million SEK for 2023 Q3, up 31.55% from previous quarter.

Annual Total Liabilities Chart of SenzaGen AB (2023 - 2014)

Historical Annual Total Liabilities of SenzaGen AB (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	29.56 Million SEK	-2.26%
2022	30.25 Million SEK	28.4%
2021	23.56 Million SEK	527.32%
2020	3.75 Million SEK	-57.07%
2019	8.74 Million SEK	93.01%
2018	4.53 Million SEK	-40.86%
2017	7.66 Million SEK	246.68%
2016	2.21 Million SEK	-40.95%
2015	3.74 Million SEK	50.06%
2014	2.49 Million SEK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	26.67 Million SEK	1.37%
2024 Q1	26.31 Million SEK	-10.99%
2023 Q3	29.56 Million SEK	31.55%
2023 Q1	22.47 Million SEK	-25.7%
2023 FY	29.56 Million SEK	-2.26%
2023 Q4	29.56 Million SEK	0.0%
2023 Q2	22.47 Million SEK	0.0%
2022 Q3	30.25 Million SEK	71.8%
2022 Q4	30.25 Million SEK	0.0%
2022 FY	30.25 Million SEK	28.4%
2022 Q2	17.6 Million SEK	70.48%
2022 Q1	10.32 Million SEK	-56.16%
2021 Q1	2.15 Million SEK	-42.73%
2021 FY	23.56 Million SEK	527.32%
2021 Q4	23.56 Million SEK	0.0%
2021 Q3	23.56 Million SEK	493.65%
2021 Q2	3.96 Million SEK	84.52%
2020 Q3	3.75 Million SEK	-0.08%
2020 Q1	2.05 Million SEK	-76.5%
2020 Q2	3.75 Million SEK	82.83%
2020 FY	3.75 Million SEK	-57.07%
2020 Q4	3.75 Million SEK	0.0%
2019 Q4	8.74 Million SEK	54.66%
2019 FY	8.74 Million SEK	93.01%
2019 Q2	5.29 Million SEK	33.48%
2019 Q1	3.96 Million SEK	-12.57%
2019 Q3	5.65 Million SEK	6.94%
2018 Q2	9.14 Million SEK	222.15%
2018 Q3	4.53 Million SEK	-50.45%
2018 Q4	4.53 Million SEK	0.0%
2018 Q1	2.84 Million SEK	-62.95%
2018 FY	4.53 Million SEK	-40.86%
2017 Q3	7.66 Million SEK	-26.55%
2017 Q4	7.66 Million SEK	0.0%
2017 Q1	3.63 Million SEK	64.18%
2017 Q2	10.43 Million SEK	187.47%
2017 FY	7.66 Million SEK	246.68%
2016 FY	2.21 Million SEK	-40.95%
2016 Q3	2.21 Million SEK	0.0%
2016 Q4	2.21 Million SEK	0.0%
2016 Q1	- SEK	0.0%
2015 FY	3.74 Million SEK	50.06%
2014 FY	2.49 Million SEK	0.0%

Peer Total Liabilities Comparison of SenzaGen AB

Name	Total Liabilities	Total Liabilities Difference
AroCell AB (publ)	11.24 Million SEK	-162.92%
Devyser Diagnostics AB (publ)	125 Million SEK	76.346%
Immunovia AB (publ)	31.69 Million SEK	6.696%
Prostatype Genomics AB (publ)	24.54 Million SEK	-20.45%
Spermosens AB	13.41 Million SEK	-120.443%